Mark Winderlich

Insider Reports History

Entity
Individual
Location
C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Winderlich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Chief Development Officer Stock Option (Right to Buy) 50K Apr 15, 2024 Direct

Insider Reports Filed by Mark Winderlich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOOK HOOKIPA Pharma Inc. Apr 15, 2024 2 $0 4 Apr 17, 2024 Chief Development Officer
HOOK HOOKIPA Pharma Inc. Apr 1, 2024 0 $0 3 Apr 11, 2024 Chief Development Officer